Oldest pages

Jump to navigation Jump to search

Showing below up to 100 results in range #251 to #350.

View (previous 100 | next 100) (20 | 50 | 100 | 250 | 500)

  1. Connective tissue‏‎ (19:21, 12 September 2019)
  2. Consequential late effects‏‎ (19:21, 12 September 2019)
  3. Constancy test‏‎ (19:21, 12 September 2019)
  4. Contamination‏‎ (19:22, 12 September 2019)
  5. Coronary heart disease‏‎ (19:23, 12 September 2019)
  6. Cost-benefit analysis‏‎ (19:24, 12 September 2019)
  7. Coster-Kronig transition‏‎ (19:25, 12 September 2019)
  8. Curie‏‎ (19:25, 12 September 2019)
  9. Cytokines‏‎ (19:26, 12 September 2019)
  10. Decay constant‏‎ (19:28, 12 September 2019)
  11. Decommissioning‏‎ (19:28, 12 September 2019)
  12. Decontamination‏‎ (19:29, 12 September 2019)
  13. Decontamination factor‏‎ (19:29, 12 September 2019)
  14. Deontological Ethics‏‎ (19:30, 12 September 2019)
  15. Diastasis‏‎ (19:30, 12 September 2019)
  16. Dichotomous‏‎ (19:31, 12 September 2019)
  17. Differentiation‏‎ (19:31, 12 September 2019)
  18. In vivo radiobioassay‏‎ (19:32, 12 September 2019)
  19. Disposal‏‎ (19:33, 12 September 2019)
  20. DNA damage signalling‏‎ (19:33, 12 September 2019)
  21. Dose constraint‏‎ (19:35, 12 September 2019)
  22. Dose criteria‏‎ (19:35, 12 September 2019)
  23. Dose limit‏‎ (19:36, 12 September 2019)
  24. Dose per unit intake coefficient‏‎ (19:37, 12 September 2019)
  25. Dose rate‏‎ (19:38, 12 September 2019)
  26. Dose rate effectiveness factor‏‎ (19:38, 12 September 2019)
  27. Dose-rate effect‏‎ (19:39, 12 September 2019)
  28. Dose-threshold‏‎ (19:40, 12 September 2019)
  29. Early normal tissue responses‏‎ (19:43, 12 September 2019)
  30. Edema‏‎ (19:44, 12 September 2019)
  31. Effect Dose 50‏‎ (19:45, 12 September 2019)
  32. Effective charge number‏‎ (19:46, 12 September 2019)
  33. Effective dose equivalent‏‎ (19:47, 12 September 2019)
  34. Effective half-life‏‎ (19:49, 12 September 2019)
  35. Electron-capture decay‏‎ (19:49, 12 September 2019)
  36. Electrophysiology‏‎ (19:51, 12 September 2019)
  37. Emergency‏‎ (19:52, 12 September 2019)
  38. Emergency exposure situation‏‎ (19:52, 12 September 2019)
  39. Emergency plan‏‎ (19:53, 12 September 2019)
  40. Emergency preparedness‏‎ (19:53, 12 September 2019)
  41. Emergency procedures‏‎ (19:53, 12 September 2019)
  42. Endogeneous excretion‏‎ (19:54, 12 September 2019)
  43. Environmental exposure‏‎ (19:55, 12 September 2019)
  44. Environmental radiation protection‏‎ (19:55, 12 September 2019)
  45. Epithelium‏‎ (19:56, 12 September 2019)
  46. Erythropoietin‏‎ (19:57, 12 September 2019)
  47. Ethics‏‎ (19:58, 12 September 2019)
  48. Exempt waste‏‎ (19:59, 12 September 2019)
  49. Exemption level‏‎ (19:59, 12 September 2019)
  50. Existing exposure situation‏‎ (20:00, 12 September 2019)
  51. Exponential survival curve‏‎ (20:01, 12 September 2019)
  52. Exposure, external or internal‏‎ (20:01, 12 September 2019)
  53. Exposure situation‏‎ (20:02, 12 September 2019)
  54. Habitual mouth breather‏‎ (12:42, 13 September 2019)
  55. Habitual nose breather‏‎ (12:42, 13 September 2019)
  56. Half-life, physical‏‎ (12:43, 13 September 2019)
  57. Hazard‏‎ (12:43, 13 September 2019)
  58. Health Surveillance‏‎ (12:43, 13 September 2019)
  59. Heliosphere‏‎ (12:44, 13 September 2019)
  60. Hierarchical tissues‏‎ (12:44, 13 September 2019)
  61. High level waste‏‎ (12:45, 13 September 2019)
  62. Hormones‏‎ (12:45, 13 September 2019)
  63. Hyperbaric oxygen‏‎ (12:46, 13 September 2019)
  64. Hypertrophic cardiomyopathy‏‎ (12:48, 13 September 2019)
  65. Hypoplasia‏‎ (12:48, 13 September 2019)
  66. Immune system‏‎ (12:49, 13 September 2019)
  67. Incident‏‎ (12:50, 13 September 2019)
  68. Inclusiveness‏‎ (12:50, 13 September 2019)
  69. Individual decontamination‏‎ (12:50, 13 September 2019)
  70. Individual monitoring‏‎ (12:51, 13 September 2019)
  71. Individual-related‏‎ (12:51, 13 September 2019)
  72. Inhalability‏‎ (12:53, 13 September 2019)
  73. Inner bremsstrahlung‏‎ (12:53, 13 September 2019)
  74. Institutional control‏‎ (12:54, 13 September 2019)
  75. Intermediate level waste‏‎ (12:54, 13 September 2019)
  76. Internal conversion electron‏‎ (12:56, 13 September 2019)
  77. Interphase death‏‎ (12:56, 13 September 2019)
  78. Intervention Level‏‎ (12:56, 13 September 2019)
  79. Interventional procedure‏‎ (12:57, 13 September 2019)
  80. Iso-effect plots‏‎ (12:58, 13 September 2019)
  81. Isomers‏‎ (12:58, 13 September 2019)
  82. Isotropic geometry‏‎ (12:58, 13 September 2019)
  83. Itinerant (radiation) worker‏‎ (12:59, 13 September 2019)
  84. Latent time/period or latency interval‏‎ (13:01, 13 September 2019)
  85. Limitation of dose‏‎ (13:01, 13 September 2019)
  86. Lineal energy‏‎ (13:02, 13 September 2019)
  87. Linear-non-threshold model‏‎ (13:03, 13 September 2019)
  88. Low level waste‏‎ (13:08, 13 September 2019)
  89. Lymphatic system‏‎ (13:08, 13 September 2019)
  90. Macrophage colony stimulating factor‏‎ (13:08, 13 September 2019)
  91. Magnetosphere‏‎ (13:09, 13 September 2019)
  92. Member of the public‏‎ (13:10, 13 September 2019)
  93. Mendelian diseases‏‎ (13:10, 13 September 2019)
  94. Mitigation‏‎ (13:10, 13 September 2019)
  95. Multistage tumorigenesis‏‎ (13:11, 13 September 2019)
  96. Myocardial perfusion‏‎ (13:12, 13 September 2019)
  97. Myocardial stress test‏‎ (13:13, 13 September 2019)
  98. Naturally occurring radioactive material‏‎ (13:14, 13 September 2019)
  99. Necrosis‏‎ (13:14, 13 September 2019)
  100. Neurological syndrome‏‎ (13:14, 13 September 2019)

View (previous 100 | next 100) (20 | 50 | 100 | 250 | 500)

Retrieved from "http://icrpaedia.org/Special:AncientPages"